
Servier ends clinical trials for sevasemten in both Becker and Duchenne muscular dystrophy
After the recent and disappointing news that the GRAND CANYON study in Becker muscular dystrophy did not meet its primary or key secondary endpoints, and a Governance Committee review of […]








